We are live on ! Find out more
CDIO icon

Cardio Diagnostics
CDIO

11 hedge funds and large institutions have $1.31M invested in Cardio Diagnostics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $249K → $1.31M (+$1.06M)

0.04% more ownership

Funds ownership: 0.08% → 0.12% (+0.04%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$195K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$168K
3
State Street
State Street
Massachusetts
+$110K
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$106K
5
Bank of America
Bank of America
North Carolina
+$39.4K

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$27.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$26.2K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$22.3K
4
YCM
Yakira Capital Management
Connecticut
-$22K
5
CCM
Context Capital Management
California
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
LA
1
Linden Advisors
New York
$335K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$290K +$195K +2,476 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$250K +$168K +2,134 New
State Street
4
State Street
Massachusetts
$163K +$110K +1,390 New
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$158K +$106K +1,350 New
Bank of America
6
Bank of America
North Carolina
$58.6K +$39.4K +500 New
CSC
7
Caldwell Sutter Capital
California
$31.7K – – –
UBS Group
8
UBS Group
Switzerland
$10.5K +$3.39K +43 +93%
WAM
9
Wolverine Asset Management
Illinois
$6.01K +$4.02K +51 New
TRCT
10
Tower Research Capital (TRC)
New York
$5K +$3.39K +43 New
Wells Fargo
11
Wells Fargo
California
$160 – – –
PAMP
12
Polar Asset Management Partners
Ontario, Canada
– -$27.2K -857 Closed
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$26.2K -788 Closed
YCM
14
Yakira Capital Management
Connecticut
– -$22K -692 Closed
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
– -$22.3K -669 Closed
CCM
16
Context Capital Management
California
– -$17K -543 Closed
ASM
17
ATW SPAC Management
New York
– -$14.4K -452 Closed
BFM
18
Boothbay Fund Management
New York
– -$14.4K -452 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$3 – –

CDIO Hedge Fund Activity: Q1 2023 in Review

11 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q1 2023, worth a combined $1.31M — up 426% from $249K a quarter earlier.

Fund positioning in CDIO was balanced in Q1 2023: 7 funds opened new positions, 7 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $195K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $27.2K sold.

  • 11 institutional investors held Cardio Diagnostics (CDIO) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $1.31M of Cardio Diagnostics stock for Q1 2023, up 426% quarter-over-quarter.
  • 7 funds opened new Cardio Diagnostics positions in Q1 2023 and 7 closed out, a net change of 0 holders.
  • The largest Cardio Diagnostics buyer in Q1 2023 was Geode Capital Management, an estimated $195K added.
  • The largest Cardio Diagnostics seller in Q1 2023 was Polar Asset Management Partners, an estimated $27.2K sold.

Based on aggregated 13F filings for Q1 2023.